Cargando…

Podcast on the Management of Adverse Events Associated with Lorlatinib

SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s12325-022-02050-3.

Detalles Bibliográficos
Autores principales: Bauer, Todd M., Bertino, Erin M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8989848/
https://www.ncbi.nlm.nih.gov/pubmed/35147918
http://dx.doi.org/10.1007/s12325-022-02050-3
_version_ 1784683260884811776
author Bauer, Todd M.
Bertino, Erin M.
author_facet Bauer, Todd M.
Bertino, Erin M.
author_sort Bauer, Todd M.
collection PubMed
description SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s12325-022-02050-3.
format Online
Article
Text
id pubmed-8989848
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-89898482022-04-22 Podcast on the Management of Adverse Events Associated with Lorlatinib Bauer, Todd M. Bertino, Erin M. Adv Ther Commentary SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s12325-022-02050-3. Springer Healthcare 2022-02-11 2022 /pmc/articles/PMC8989848/ /pubmed/35147918 http://dx.doi.org/10.1007/s12325-022-02050-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Commentary
Bauer, Todd M.
Bertino, Erin M.
Podcast on the Management of Adverse Events Associated with Lorlatinib
title Podcast on the Management of Adverse Events Associated with Lorlatinib
title_full Podcast on the Management of Adverse Events Associated with Lorlatinib
title_fullStr Podcast on the Management of Adverse Events Associated with Lorlatinib
title_full_unstemmed Podcast on the Management of Adverse Events Associated with Lorlatinib
title_short Podcast on the Management of Adverse Events Associated with Lorlatinib
title_sort podcast on the management of adverse events associated with lorlatinib
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8989848/
https://www.ncbi.nlm.nih.gov/pubmed/35147918
http://dx.doi.org/10.1007/s12325-022-02050-3
work_keys_str_mv AT bauertoddm podcastonthemanagementofadverseeventsassociatedwithlorlatinib
AT bertinoerinm podcastonthemanagementofadverseeventsassociatedwithlorlatinib